SLDB compared with CCCC: revenue, margins and what each company keeps, and the suppliers and customers both name

SLDBSolid Biosciences Inc.

Mkt capRevenueRevenue

CCCCC4 Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SLDBSolid Biosciences Inc.

CCCCC4 Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

SLDBSolid Biosciences Inc.

6.20▼−2.97%· post 6.20

Mkt cap$664.8MRevenue—Revenue—

CCCCC4 Therapeutics, Inc.

3.36▲+1.77%· post 3.36

ClosedOct 30 '26

Mkt cap$414.6MRevenue$7MQ2 FY26Revenue$36MFY25

Compare

ClosedOct 30 '26

SLDBSolid Biosciences Inc.

CCCCC4 Therapeutics, Inc.

6.20▼−2.97%post 6.20

Price

3.36▲+1.77%post 3.36

$664.8M

Mkt cap

$414.6M

—

Revenue

$7MQ2 FY26

—

Revenue

$36MFY25

SLDB6.20▼−2.97%vsCCCC3.36▲+1.77%ClosedOct 30 '26

Price

rebased to 0%

SLDB, solidCCCC, dashed

Supply-chain overlap

Revenue flow

SLDB: latest quarter not drawable. CCCC: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SLDB 7

—FA212unlistedsupplier

—ICS Maugeriunlistedsupplier

—University of Pennsylvaniaunlistedsupplier

—University of Washingtonunlistedsupplier

3 more · SLDB chain ›

Shared 0

No shared counterparties.

Only CCCC 6

MRKMerckcustomer

PFEPfizersupplier

BIIBBiogen MAcustomer

—Betta Pharmaunlisted

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

customer

2 more · CCCC chain ›